Figure 2.
Figure 2. ADAMTS13 mutation in the patient with congenital TTP. DNA sequence chromatograms corresponding to ADAMTS13 exon 15 are shown here for PCR-amplified genomic DNA from a healthy control (A), the patient (B), the patient's mother (C), and the patient's father (D). The patient DNA exhibits a homozygous 2-nucleotide (TT) deletion at the end of exon 15 (corresponding to position 1783-1784 of the ADAMTS13 cDNA), resulting in a frameshift after His594, followed by a predicted 18–amino acid extension and premature termination. The DNA chromatograms from both parents demonstrate superimposed normal and deletion allele sequences, indicating that they are heterozygous for this mutation.

ADAMTS13 mutation in the patient with congenital TTP. DNA sequence chromatograms corresponding to ADAMTS13 exon 15 are shown here for PCR-amplified genomic DNA from a healthy control (A), the patient (B), the patient's mother (C), and the patient's father (D). The patient DNA exhibits a homozygous 2-nucleotide (TT) deletion at the end of exon 15 (corresponding to position 1783-1784 of the ADAMTS13 cDNA), resulting in a frameshift after His594, followed by a predicted 18–amino acid extension and premature termination. The DNA chromatograms from both parents demonstrate superimposed normal and deletion allele sequences, indicating that they are heterozygous for this mutation.

Close Modal

or Create an Account

Close Modal
Close Modal